Thu, Aug 21, 2014, 4:46 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Amylin Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • terry_amln terry_amln Nov 11, 2010 3:46 PM Flag

    Experts comment on FDA incompetence

    "ANY diabetic can use exenatide if they want to use it"

    The subject I posted is Bydureon - a much different drug( and why the FDA is dealing with it as a new drug)
    Byduron advantages are many above Byetta,mainly the NAUSEA is MUCH less because of the dosing- this was one of the big reasons Byetta was never a blockbuster.
    The numbers that will take Bydureon will be much larger because of the next big reason that the stall will affect so many- COMPLIANCE- compliance among diabetics is well known to be poor,and many on Byetta would often not take a second shot and the drugs effects would falter.Its not stupid that the reasons that this stall will affect so many is because it will be prescribed to a far larger diabetic population.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.